The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses.
 
Robin Kate Kelley
Consulting or Advisory Role - Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst)
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Exelixis (Inst); Lilly (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Target Pharmasolutions (Inst); Tekmira (Inst)
 
Emily Mitchell
No Relationships to Disclose
 
Spencer Behr
Honoraria - GE Healthcare
Consulting or Advisory Role - GE Healthcare (Inst)
Research Funding - GE Healthcare
 
Jimmy Hwang
No Relationships to Disclose
 
Bridget Keenan
No Relationships to Disclose
 
Sarah E Umetsu
No Relationships to Disclose
 
John Dozier Gordan
No Relationships to Disclose
 
Andrew H. Ko
Honoraria - Advance Medical; Biomedical Learning Institute; Med IQ; Medscape; Peerview; Pharmatecture; WebMD
Consulting or Advisory Role - ARMO Biosciences; AstraZeneca; Celgene; New B Innovation; Pharmacyclics; Rafael Pharmaceuticals; Seagen; Vicus Therapeutics
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst)
 
Pelin Cinar
Research Funding - Newlink Genetics
 
Chloe Evelyn Atreya
Consulting or Advisory Role - Genentech; Kura Oncology
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Guardant Health; Merck; Novartis
Travel, Accommodations, Expenses - Roche
 
Katherine Van Loon
Consulting or Advisory Role - Bayer (Inst)
 
Thomas Weber
No Relationships to Disclose
 
Zoe Ngo
No Relationships to Disclose
 
Zoe E. Quandt
No Relationships to Disclose
 
Chienying Liu
No Relationships to Disclose
 
Alan P. Venook
Consulting or Advisory Role - Bayer; Halozyme; Merrimack; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Genentech; Halozyme; Roche; Taiho Pharmaceutical
 
Lawrence Fong
Consulting or Advisory Role - Atreca; IDEAYA Biosciences; MIODx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)